Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer.
Chia-Chi ChenWei-Hua TangCheng-Ching WuThung-Lip LeeI-Ting TsaiChin-Feng HsuanChao-Ping WangFu-Mei ChungYau-Jiunn LeeTeng-Hung YuChing-Ting WeiPublished in: Breast cancer (Dove Medical Press) (2024)
In addition to the traditional predictors of worse DFS such as AJCC stage III and Ki67 ≥14%, lower pretreatment circulating albumin, higher pretreatment circulating platelet count and RDW-SD could significantly predict worse DFS in this study, and SEM delineated possible causal pathways and inter-relationships of albumin, platelet, and RDW-SD contributing to the disease recurrence among Chinese women with breast cancer.
Keyphrases